Frontiers in Public Health | |
Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis | |
article | |
Gopiram Syangtan1  Shrijana Bista2  Prabin Dawadi2  Binod Rayamajhee3  Lok Bahadur Shrestha5  Reshma Tuladhar2  Dev Raj Joshi2  | |
[1] Shi-Gan International College of Science and Technology (SICOST), Tribhuvan University;Central Department of Microbiology, Tribhuvan University;Faculty of Science, School of Optometry and Vision Science (SOVS), University of New South Wales (UNSW);Department of Infection and Immunology, Kathmandu Research Institute for Biological Sciences (KRIBS);Department of Microbiology and Infectious Diseases, B. P. Koirala Institute of Health Sciences | |
关键词: asymptomatic; COVID-19; 2019-nCoV; pandemic; SARS-CoV-2; transmission; | |
DOI : 10.3389/fpubh.2020.587374 | |
学科分类:社会科学、人文和艺术(综合) | |
来源: Frontiers | |
【 摘 要 】
Asymptomatic cases of SARS-CoV-2 can be unknown carriers magnifying the transmission of COVID-19. This study appraised the frequency of asymptomatic individuals and estimated occurrence by age group and gender by reviewing the existing published data on asymptomatic people with COVID-19. Three electronic databases, PubMed, Embase, and Web of Science (WoS), were used to search the literature following the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). The study population for this review included asymptomatic individuals infected with SARS-CoV-2 reported in original articles published up to 30 April 2020. A random effects model was applied to analyze pooled data on the prevalence of asymptomatic cases among all COVID-19 patients and also by age and gender. From the meta-analysis of 16 studies, comprising 2,788 SARS-CoV-2 infected patients, the pooled prevalence according to the random effect size of asymptomatic cases was 48.2% (95% CI, 30–67%). Of the asymptomatic cases, 55.5% (95% CI, 43.6–66.8%) were female and 49.6% (95% CI, 20.5–79.1%) were children. Children and females were more likely to present as asymptomatic COVID-19 cases and could act as unknown carriers of SARS-CoV-2. Symptom-based screening might fail to identify all SARS-CoV-2 infections escalating the threat of global spread and impeding containment. Therefore, a mass surveillance system to track asymptomatic cases is critical, with special attention to females and children.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202108170002547ZK.pdf | 1664KB | download |